- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
OssDsign surpasses IPO target
Karolinska Development-backed regenerative implant producer OssDsign has booked $15.8m after selling out the original issue for its forthcoming listing, and is now looking to generate up to $2.4m from the overallotment.
May 28, 2019A lack of vision will come to haunt us all
May issue editorial by Thierry Heles, editor, Global University Venturing
May 28, 2019Medherant measures up to $3m
Mercia Technologies has returned to back Warwick-founded medtech spinout Medherant, which is preparing to advance its adhesive Tepi Patch technology through the clinic.
May 28, 2019Cardinal Analytx ticks off $23m series B
GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer based on Stanford research.
May 28, 2019Quick insights from our GCV Founders survey
In February and March 2019, we conducted a small pilot survey (n=31) of founders of businesses that have received corporate funding, which were referred to the survey by their corporate backers. We called it the “GCV Founders Survey” and it gave us some interesting insights.
May 28, 2019AlloVir secures $120m funding allocation
The T-Cell therapy developer, based on research at Baylor College of Medicine, has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.
May 28, 2019Pixie Dust cleans up with series B funding
Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.
May 24, 2019PSL Innovation Fund reaches $72.3m
The intermediary close of PSL's deep tech-oriented fund comes after additional contributions from the EIF, Bpifrance and Vilmorin & Cie.
May 24, 2019Bicycle Therapeutics squares $60.7m IPO circle
Cambridge Innovation Capital has celebrated an exit as Bicycle Therapeutics successfully lists in the US.
May 24, 2019GCV Symposium 2019: Global Data Insights and Benchmarks
Data presented by Martin Haemmig and GCV Analytics provided insight into the substantial growth in corporate venturing along with some of the major trends.
May 24, 2019GCV Powerlist 2019 Introduction
Introduction to the Global Corporate Venturing Powerlist 2019 by James Mawson, editor-in-chief
May 23, 2019Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
